Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 16:8:598997.
doi: 10.3389/fbioe.2020.598997. eCollection 2020.

Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells

Affiliations

Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells

Jingxia Tian et al. Front Bioeng Biotechnol. .

Abstract

Objective: To investigate the effects of selenium nanoparticles (nano-Se) combined with radiotherapy on the proliferation, migration, invasion, and apoptosis of non-small cell lung cancer (NSCLC) A549 and NCI-H23 cells.

Methods: Nano-Se was synthesized and characterized by transmission electron microscope (TEM), X-ray diffractometer, and Ultraviolet-visible (UV)-Vis Spectroscopy, separately. The uptake of nano-Se by lung cancer cells was detected by flow cytometry. Cell counting kit-8 (CCK-8) method was used to detect the antiproliferative activity of nano-Se combined with radiotherapy. Wound healing tests and transwell assay were used to detect the migration and invasion ability of the cells. Annexin V-fluorescein isothiocyanate (FITC)/Propidium iodide (PI) staining by flow cytometry was used to detect apoptosis. The expression of Cyclin D1 (CCND1), c-Myc, matrix metalloproteinase 2 (MMP2), MMP9, cleaved Caspase-3, and cleaved Caspase-9 were detected by Western blot.

Results: The average diameter of nano-Se was 24.39 nm and the wavelength of nano-Se increased with the increase of radiation dose under UV-Vis Spectroscopy. The uptake of nano-Se in lung cancer cells was increased with the increase of nano-Se concentration. The nano-Se combined with radiotherapy decreased the proliferation activity of NSCLC cell lines A549 and NCI-H23 in a dose-dependent manner (all P < 0.05). Compared with the Control group, nano-Se combined with radiotherapy could significantly inhibit the migration and invasion of lung cancer cells (all P < 0.05), and the effects of the combination of nano-Se and radiotherapy was better than that of a single application (all P < 0.05). Furthermore, nano-Se combined with radiotherapy could induce apoptosis of lung cancer cells (P < 0.05) and nano-Se combined with radiotherapy could significantly inhibit the expression of proliferation-related proteins CCND1, c-Myc, invasion and migration-related proteins MMP2 and MMP9, but conversely promoted the expression of apoptosis-related proteins cleaved caspase-3 and cleaved caspase-9. Conclusion: This study found that nano-Se combined with radiotherapy plays an anti-cancer role in lung cancer cells by inhibiting cell proliferation, migration, and invasion, as well as inducing apoptosis, suggesting that nano-Se may be used as a radiosensitizer in the clinical treatment of lung cancer, but further research is still needed.

Keywords: combination; lung cancer; radiotherapy; selenium nanoparticle; synergistic therapy.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Characterization and identification of Nano-Se. (A,B) Observe the morphological size of nano-Se by TEM and draw a size histogram; (C) XRD analysis; (D) UV-Vis Spectroscopy analysis.
FIGURE 2
FIGURE 2
The effect of Nano-Se and its combination with radiotherapy on cell proliferation activity. (A,B) The effects of different concentrations of nano-Se (0 (Control), 0.25, 0.5, 1, 2, 5, 10, 15, and 20 μg/mL) on the proliferation of NSCLC cells A549 and NCI-H23; (C,D) After 1 μg/mL nano-Se pretreated NSCLC cells A549 and NCI-H23, the effects of different doses of radiation treatment (0 (Control), 2, 4, and 6 Gy) on cell proliferation activity. Compared with the Control group, **P < 0.01, ***P < 0.001; comparison between different concentrations of nano-Se treatment group, ###P < 0.001; comparison between different dose radiation treatment groups, &&P < 0.01, &&&P < 0.001.
FIGURE 3
FIGURE 3
The uptake of Nano-Se by NSCLC cells. (A–E) Nano-Au, different concentrations of nano-Se (0, 0.5, and 1 μg/mL) treated A549 cells, the cell absorption of nanoparticles.
FIGURE 4
FIGURE 4
The effects of Nano-Se combined with radiotherapy on cell migration. (A) The migration changes of A549 cells; (B) The migration changes of NCI-H23 cells. Compared with the Control group, *P < 0.05.
FIGURE 5
FIGURE 5
The effects of Nano-Se combined with radiotherapy on cell invasion. (A) Invasion of A549 cells; (B) Invasion of NCI-H23 cells. Compared with the Control group, *P < 0.05, **P < 0.01.
FIGURE 6
FIGURE 6
The effects of Nano-Se combined with radiotherapy on cell apoptosis. (A) Apoptosis of A549 cells; (B) Apoptosis of NCI-H23 cells. Compared with the Control group, *P < 0.05, **P < 0.01, ***P < 0.001.
FIGURE 7
FIGURE 7
The effects of Nano-Se combined with radiotherapy on the level of protein expression in cells. Compared with the Control group, *P < 0.05, **P < 0.01, ***P < 0.001.
FIGURE 8
FIGURE 8
Mechanism pathway diagram of nano-Se acting on NSCLC cells.

Similar articles

Cited by

References

    1. Bagcchi S. (2017). Lung cancer survival only increases by a small amount despite recent treatment advances. Lancet Respir. Med. 5:169 10.1016/s2213-2600(17)30041-3 - DOI - PubMed
    1. Bhattacharjee A., Basu A., Ghosh P., Biswas J., Bhattacharya S. (2014). Protective effect of Selenium nanoparticle against cyclophosphamide induced hepatotoxicity and genotoxicity in Swiss albino mice. J. Biomater. Appl. 29 303–317. 10.1177/0885328214523323 - DOI - PubMed
    1. Bi X., Pohl N., Dong H., Yang W. (2013). Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice. J. Hematol. Oncol. 6:8. 10.1186/1756-8722-6-8 - DOI - PMC - PubMed
    1. Bi Y. L., Min M., Shen W., Liu Y. (2018). Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G0/G1cell cycle arrest and regulation of STAT3 signalling pathway. Phytomedicine 39 10–16. 10.1016/j.phymed.2017.12.001 - DOI - PubMed
    1. Cai W., Mastrandrea N., Tham K., Monks T., Lau S. (2014). Pentoxifylline induces GSK-3β−independent proteasomal degradation of cyclin D1 and arrests renal cancer cells in the G1 phase (616.5). Int. J. Biochem. Cell Biol. 54 223–235. - PubMed